Crude Oil Falls Sharply; Apollomics Shares Plunge
Portfolio Pulse from Lisa Levin
U.S. stocks traded mixed with the Nasdaq Composite gaining over 100 points. Energy shares dipped by 1.9% while communication services shares rose by 1.3%. LumiraDx Limited, INVO Bioscience, and Akumin Inc. saw significant gains after strategic collaborations and acquisitions. Li-Cycle Holdings Corp., Revolution Medicines, and Apollomics, Inc. saw significant drops due to halted projects and clinical trial data. Oil traded down 2.6% to $85.79.
October 23, 2023 | 6:39 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Apollomics, Inc. was down, falling 43% after the company announced the presentation of vebreltinib efficacy and safety data from the KUNPENG clinical trial.
The presentation of vebreltinib efficacy and safety data from the KUNPENG clinical trial is a negative development for Apollomics, Inc., which is likely to decrease investor confidence and drive the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Li-Cycle Holdings Corp. shares dropped 44% after the company announced plans to halt construction work on its Rochester Hub project.
The announcement of halting construction work on its Rochester Hub project is a negative development for Li-Cycle Holdings Corp., which is likely to decrease investor confidence and drive the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Revolution Medicines shares were down 39% after the company announced it presented clinical activity and safety data from its Phase 1/1b trial of RMC-6236.
The presentation of clinical activity and safety data from its Phase 1/1b trial of RMC-6236 is a negative development for Revolution Medicines, which is likely to decrease investor confidence and drive the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Akumin Inc. shares were up, gaining 149% after the company reached an agreement with Stonepeak to become a private company.
The agreement with Stonepeak to become a private company is a positive development for Akumin, which is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
INVO Bioscience shares shot up 295% as the company agreed to acquire NAYA Biosciences in an all-stock transaction.
The acquisition of NAYA Biosciences is a positive development for INVO Bioscience, which is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
LumiraDx Limited shares shot up 282% after the company reported a strategic collaboration with AstraZeneca and Everton in the Community.
The strategic collaboration is a positive development for LumiraDx, which is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100